Udai Banerji's Avatar

Udai Banerji

@udaibanerji

Clinician Scientist, passionate translational medicine and drug discovery in oncology and beyond...

65
Followers
19
Following
20
Posts
29.12.2024
Joined
Posts Following

Latest posts by Udai Banerji @udaibanerji

Post image

Seville (bitter) oranges some times used for marmalade or juice but not usually edible as an oranges contain furanocumarins, CYP3A4 inhibitors that increase levels of drugs metabolised by CYP3A4.

27.02.2026 16:19 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

Fuelling the qest for the next generation of clinician scientists. Great opportunity!

13.11.2025 18:52 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

PhD convocation ceremony at @icr.ac.uk with DrDr Alvaro Graces. His thesis entitled Clonal Dynamics and evolutionary pathways in high grade serous ovarian cancer under therapeutic pressure siggests our current use of chemotherapy can be better optimised. @trevorgraham.bsky.social

01.11.2025 12:31 πŸ‘ 2 πŸ” 0 πŸ’¬ 0 πŸ“Œ 1
Post image Post image

Interesting insights into phase I trial recruitment in oncology and health care utilization using data extracted from unstructured text in health care records. pubmed.ncbi.nlm.nih.gov/40855012/ @icr.ac.uk @royalmarsden.org @ecmc-uk.bsky.social @crukconvergence.bsky.social @nihr.bsky.social

29.08.2025 13:43 πŸ‘ 3 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image Post image

Organoid culture is prohibitively expensive. Solution to Harvest Organoids Efficiently (SHOE) allows rapid and inexpensive harvesting of organoids. Please use in your research labs and cite. pubmed.ncbi.nlm.nih.gov/40641211/ @icr.ac.uk @royalmarsden.org @crukconvergence.bsky.social

14.07.2025 16:09 πŸ‘ 4 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Antibody-drug-conjugate toxicity is real and poorly understood. Looking for trends in association with antibody/linker/payloads. pubmed.ncbi.nlm.nih.gov/40611310/ @icr.ac.uk @royalmarsden.org @ecmc-uk.bsky.social @crukconvergence.bsky.social

08.07.2025 10:07 πŸ‘ 6 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image Post image

Published today @natmed.nature.com www.nature.com/articles/s41...
Thank you to all patients, families and research staff. @icr.ac.uk @icrdduiit.bsky.social‬ β€ͺ@icr-ctsu.bsky.social @royalmarsden.org @ecmc-uk.bsky.social‬
@nihr.bsky.social @crukconvergence.bsky.social @cancerresearchuk.org

β€ͺ

27.06.2025 10:48 πŸ‘ 4 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image Post image Post image Post image

Published today in @natmed.nature.com www.nature.com/articles/s41... combination of avutometinib and defactinib in LGSOC. @icr.ac.uk‬ @icrdduiit.bsky.social‬ @icr-ctsu.bsky.social @royalmarsden.org @ecmc-uk.bsky.social
@nihr.bsky.social‬ β€ͺ@crukconvergence.bsky.social @cancerresearchuk.org

β€ͺ

27.06.2025 10:39 πŸ‘ 2 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

#MCCR2025. Methods in clinical cancer research workshop hits its 25 year birthday! Fabulous opportunity to train young oncologists to develop research protocols. Especially proud to have been a trainee over 20 years ago and having served as faculty. @ESMO @EORTC @theaacr.bsky.social

19.06.2025 21:04 πŸ‘ 2 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Sharing good practice to run complex radio-immuno conjugate trials in the UK to accelerate drug development and improve outcomes of cancer patients. @ecmc.bsky.social @icr.ac.uk @icrdduiit.bsky.social @nihr.bsky.social @cruk.bsky.social

07.05.2025 11:19 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image Post image

Professor Paul Workman, fellow of AACR, talking on the urgency in developing chemical probes to fight cancer. #AACR2025 @icr.ac.uk

29.04.2025 23:58 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image Post image Post image Post image

End of a long day at AACR. Presented using patient derived organoids to understand and refine mechanisms of synergy of avutometinib and defactinb combination in low grade ovarian, an area of unmet need. @icr.ac.uk @crukconvergence.bsky.social @nihr.bsky.social @ecmc-uk.bsky.social

29.04.2025 23:51 πŸ‘ 1 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0

Love the art 🎨, only advice, make sure you patent anything important before you publish (on your sleeve)!! πŸ™‚ #AACR2025

28.04.2025 14:54 πŸ‘ 2 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Post image Post image

Masterclass in next generation ADCs! ED11 #AACR2025 worth watching online if you missed it.

26.04.2025 16:35 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Only at #AACR 2025, Love the commitment!!!

26.04.2025 16:23 πŸ‘ 2 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Post image Post image

#AACR2025 has begun. Educational sessions on plasticity/drug resistance and models of cancer evolution. Feel the buzz! @icr.ac.uk @cancerresearchuk.org @nihr.bsky.social

25.04.2025 23:55 πŸ‘ 3 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Happy retirement to my wife Jane, joined nurse training 42 years ago, worked across several NHS trusts and Australian public hospitals on clinical trials of carboplatin, VP16 (etoposide), GCSF, ondansetron and CHART RT in clinic. Worked in tral management @icr since 2005. Time to put up your feet!

26.02.2025 19:00 πŸ‘ 3 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

www.icr.ac.uk/about-us/icr... Blog about projects @icrlondon.bsky.social in ovarian cancer. Its only the tip of the iceberg, there are many exciting projects too early to talk about! Blessed to be a small cog in the big wheel of progress in cancer research at my institution and beyond…

24.01.2025 06:16 πŸ‘ 5 πŸ” 5 πŸ’¬ 0 πŸ“Œ 0
Preview
NXP800 activates the unfolded protein response, altering AR and E2F function to impact castration-resistant prostate cancer growth Abstract. Purpose: Advanced prostate cancer (PCa) is invariably fatal with the androgen receptor (AR) being a major therapeutic target. AR signaling inhibitors have improved overall survival for men w...

Unfolded protein response meets AR transcription. We need to think out the box to tackle known oncogenic drivers. Great piece of work from my colleague @AdamSharpMedOnc out this week aacrjournals.org/clincancerre... @icrlondon.bsky.social @theaacr.bsky.social

11.01.2025 06:12 πŸ‘ 3 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial - Nature Medicine In this phase 1 trial, patients with locally advanced or metastatic solid tumors were treated with the individualized mRNA neoantigen-specific immunotherapy (iNeST) autogene cevumeran alone or in comb...

Very interesting personalized m-RNA cancer vaccine paper in nature medicine www.nature.com/articles/s41... published this week establishing proof concept of the technology. Trial was led by my colleague Juantia Lopez and our unit was involved as part of an international clinical trial.

08.01.2025 06:05 πŸ‘ 6 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0